SERPINB3 and neoplasm: On day 4, several tumor markers were measured, including squamous cell carcinoma antigen (SCC), soluble interleukin-2 receptor, and progastrin-releasing peptide (proGRP) (Table 2), which were not considered to be significantly elevated in a patient with end-stage renal failure.